Shuttle Pharmaceuticals Holdings, Inc. Contracts & Agreements

Securities Purchase Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Diagnostics, Inc. and SRO LLC (Filed With SEC on February 13, 2024)

Placement Agent and Advisory Services Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc. and Boustead Securities, LLC (Filed With SEC on February 13, 2024)

Offering Deposit Account Agency Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Boustead Securities, LLC and Sutter Securities Inc (Filed With SEC on February 13, 2024)

Asset Purchase Agreement, dated January 30, 2024, by and between Shuttle Pharmaceuticals Holdings, Inc., Alan Kozikowksi and Werner Tueckmantel (Filed With SEC on February 5, 2024)

License Agreement, dated October 24, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc. and Georgetown University (Filed With SEC on October 30, 2023)

Consulting Agreement, dated October 1, 2023, between Shuttle Pharmaceuticals Holdings, Inc. and Joseph Armstrong (Filed With SEC on October 5, 2023)

Amendment No. 1 to the Amendment Agreement, dated June 4, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master... (Filed With SEC on June 5, 2023)

Amendment Agreement, dated May 10, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master Fund, SPC Segregated... (Filed With SEC on May 11, 2023)

Research Agreement, dated March 16, 2023, between Shuttle Pharmaceuticals, Inc. and Georgetown University (Filed With SEC on March 22, 2023)

Material Transfer Agreement, dated March 21, 2023, between Shuttle Pharmaceuticals, Inc. and Georgetown University (Filed With SEC on March 22, 2023)

Amended and Restated Insider Trading Policy, effective March 10, 2023 (Filed With SEC on March 15, 2023)

Form of Executive Compensation Clawback Policy, effective March 10, 2023 (Filed With SEC on March 15, 2023)

Letter Agreement, dated March 11, 2023, between Shuttle Pharmaceuticals Holdings, Inc. and Alto Opportunity Master Fund, SPC Segregated Portfolio B, as Collateral Agent (Filed With SEC on March 15, 2023)

Proposal for Service Agreement, dated March 7, 2023, between Shuttle Pharmaceuticals, Inc. and University of Iowa Pharmaceuticals (Filed With SEC on March 9, 2023)

Form of Director Letter Agreement (Filed With SEC on February 22, 2023)

Form of Securities Purchase Agreement (Filed With SEC on January 12, 2023)

Form of Note (Filed With SEC on January 12, 2023)

Form of Warrant (Filed With SEC on January 12, 2023)

Form of Security Agreement (Filed With SEC on January 12, 2023)

Form of Intellectual Property Security Agreement (Filed With SEC on January 12, 2023)

Form of Subsidiary Guaranty (Filed With SEC on January 12, 2023)

Form of Registration Rights Agreement (Filed With SEC on January 12, 2023)

Form of Director Offer Letter (Filed With SEC on November 1, 2022)

Manufacturing Agreement, dated September 14, 2022, between Shuttle Pharmaceuticals, Inc. and TCG GreenChem, Inc (Filed With SEC on September 19, 2022)

Form of Underwriting Agreement (Filed With SEC on August 25, 2022)

Form of 10% Promissory Note, dated August 2022 (Filed With SEC on August 25, 2022)

Form of Warrant, dated August 2022 (Filed With SEC on August 25, 2022)

Form of Public Offering Warrant (Filed With SEC on August 25, 2022)

Amendment No. 1 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on August 25, 2022)

Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals holdings, Inc. and Joy Dritschilo (Filed With SEC on August 25, 2022)

Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, inc. and Anatoly Dritschilo (Filed With SEC on August 25, 2022)

Form of Underwriting Agreement (Filed With SEC on August 24, 2022)

Form of 10% Promissory Note, dated August 2022 (Filed With SEC on August 24, 2022)

Form of Warrant, dated August 2022 (Filed With SEC on August 24, 2022)

Form of Public Offering Warrant (Filed With SEC on August 24, 2022)

Amendment No. 1 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on August 24, 2022)

Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals holdings, Inc. and Joy Dritschilo (Filed With SEC on August 24, 2022)

Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, inc. and Anatoly Dritschilo (Filed With SEC on August 24, 2022)

Form of Underwriting Agreement (Filed With SEC on August 19, 2022)

Form of 10% Promissory Note, dated August 2022 (Filed With SEC on August 19, 2022)

Form of Warrant, dated August 2022 (Filed With SEC on August 19, 2022)

Form of Public Offering Warrant (Filed With SEC on August 19, 2022)

Amendment No. 1 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on August 19, 2022)

Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals holdings, Inc. and Joy Dritschilo (Filed With SEC on August 19, 2022)

Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, inc. and Anatoly Dritschilo (Filed With SEC on August 19, 2022)

Form of Underwriting Agreement (Filed With SEC on July 13, 2022)

Form of Underwriting Agreement (Filed With SEC on June 23, 2022)

Form of Underwriting Warrant issuable to Boustead Securities LLC (Filed With SEC on June 23, 2022)

Employment Agreement, dated July 30, 2014, between Shuttle Pharmaceuticals Holdings, Inc. and Tyvin Rich (Filed With SEC on June 23, 2022)

Form of Convertible Note, dated February 2022 (Filed With SEC on June 3, 2022)

Form of Subscription Agreement for Series A Convertible Preferred Stock (Filed With SEC on June 3, 2022)

2018 Equity Incentive Plan (Filed With SEC on June 3, 2022)

Code of Business Conduct and Ethics (Filed With SEC on June 3, 2022)

Employment Agreement, dated July 30, 2014, between Shuttle Pharmaceuticals Holdings, Inc. and Tyvin Rich (Filed With SEC on June 3, 2022)

SBIR Contract #HHSN261201400013C, dated September 19, 2014, between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)

SBIR Contract #HHSN261201400013C Amendment of Solicitation/Modification of Contract, dated August 3, 2015, between Shuttle Pharmaceuticals, LLC and National Institute of Health... (Filed With SEC on June 3, 2022)

SBIR Contract #HHSN261201600027C, dated September 19, 2016, between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)

SBIR Contract #HHSN261600038C dated September 19, 2016 between Shuttle Pharmaceuticals, LLC. and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)

Material Transfer Agreement, dated April 25, 2017, between Shuttle Pharmaceuticals, Inc. and George Washington University (Filed With SEC on June 3, 2022)

Employment Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Peter Dritschilo (Filed With SEC on June 3, 2022)

Employment Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Mira Jung (Filed With SEC on June 3, 2022)

Employment Agreement, dated June 28, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly. Dritschilo (Filed With SEC on June 3, 2022)

Amended and Restated Employment Agreement, dated September 1, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Michael Vander Hoek (Filed With SEC on June 3, 2022)

Form of Letter Agreement with Director (Filed With SEC on June 3, 2022)

Subaward Agreement dated October 28, 2014 between Shuttle Pharmaceuticals, LLC and LifeSpan/Rhode Island Hospital (Filed With SEC on June 3, 2022)

Sublicense Agreement, dated February 15, 2019, between Shuttle Pharmaceuticals Inc. and Propagenix, Inc (Filed With SEC on June 3, 2022)

SBIR Contract #HHSN261201800016C/75N91018C00016 Agreement between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)

Promissory Note, dated as of August 24, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly Dritschilo (Filed With SEC on June 3, 2022)

SBIR Phase II Contract #75N9101C00031, dated September 6, 2019, between Shuttle Pharmaceuticals, Inc. and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)

Director Offer Letter, dated December 2, 2020, between Chris Senanayake and Shuttle Pharmaceuticals Holdings, Inc (Filed With SEC on June 3, 2022)

Promissory Note, dated December 1, 2020, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on June 3, 2022)

Promissory Note, dated December 1, 2020, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly Dritschilo (Filed With SEC on June 3, 2022)

Non-Disclosure, Evaluation and Option Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals, Inc. and University of Virginia Licensing & Ventures Group (Filed With SEC on June 3, 2022)

First Amendment to Non-Disclosure, Evaluation and Option Agreement, dated November 30, 2019, between Shuttle Pharmaceutical, Inc. and University of Virginia Licensing & Ventures... (Filed With SEC on June 3, 2022)

Form of Note and Warrant Subscription Agreement, dated December 28, 2021 (Filed With SEC on June 3, 2022)

Form of Note, dated December 28, 2021 (Filed With SEC on June 3, 2022)

Form of Common Stock Purchase Warrant, dated December 28, 2021 (Filed With SEC on June 3, 2022)

Consulting Agreement, dated January 1, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Steven Bayern (Filed With SEC on June 3, 2022)

Amendment to Promissory Note, dated January 25, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on June 3, 2022)

Amendment to Promissory Note, dated January 25, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly Dritschilo (Filed With SEC on June 3, 2022)

Form of Convertible Note Subscription Agreement and Investor Rights Agreement (Filed With SEC on June 3, 2022)

Category

Industry

Companies

Contracts

Shuttle Pharmaceuticals Holdings, Inc. Contracts & Agreements